Sofinnova Venture Partners IX, L.P. Insider Trading $NXTC NextCure, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sofinnova Venture Partners IX, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sofinnova Venture Partners IX, L.P.. Sofinnova Venture Partners IX, L.P. is 10% Owner in aTYR PHARMA INC ($LIFE) and 10% Owner in Iterum Therapeutics plc ($ITRM) and 10% Owner in NextCure, Inc. ($NXTC) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX).
Sofinnova Venture Partners IX, L.P. in NextCure, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sofinnova Venture Partners IX, L.P.: 10% Owner
Holdings: 2,671,856 shares
Latest Transaction: Nov 19 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Sofinnova Venture Partners IX, L.P. in NextCure, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, LIFE, ETTX, ITRM, NXTC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 19 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 36.75 | 150,000 | 5,512,500 | 2,671,856 | 2.5 M to 2.7 M (+5.95 %) |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 3,773,585 | 0 | 0 | |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 7,301,000 | 0 | 0 | |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 3,732,500 | 0 | 0 | |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Option Exercise | C | 0.00 | 2,239,500 | 0 | 0 | |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | P | 15.00 | 400,000 | 6,000,000 | 2,521,856 | 2.1 M to 2.5 M (+18.85 %) |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 469,713 | 0 | 2,121,856 | 1.7 M to 2.1 M (+28.43 %) |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 908,785 | 0 | 1,652,143 | 743.4 K to 1.7 M (+122.25 %) |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 464,599 | 0 | 743,358 | 278.8 K to 743.4 K (+166.67 %) |
| May 15 2019 | NXTC | NextCure, Inc. | Sofinnova Venture Partners IX, ... | 10% Owner | Buy | C | 0.00 | 278,759 | 0 | 278,759 | 0 to 278.8 K |
Page: 1